Literature DB >> 25288773

Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.

Stephan Kreher1, M Amine Bouhlel2, Pierre Cauchy3, Björn Lamprecht4, Shuang Li1, Michael Grau5, Franziska Hummel1, Karl Köchert1, Ioannis Anagnostopoulos6, Korinna Jöhrens6, Michael Hummel7, John Hiscott8, Sören-Sebastian Wenzel9, Peter Lenz5, Markus Schneider10, Ralf Küppers10, Claus Scheidereit11, Maciej Giefing12, Reiner Siebert13, Klaus Rajewsky11, Georg Lenz9, Peter N Cockerill3, Martin Janz1, Bernd Dörken4, Constanze Bonifer14, Stephan Mathas15.   

Abstract

Deregulated transcription factor (TF) activities are commonly observed in hematopoietic malignancies. Understanding tumorigenesis therefore requires determining the function and hierarchical role of individual TFs. To identify TFs central to lymphomagenesis, we identified lymphoma type-specific accessible chromatin by global mapping of DNaseI hypersensitive sites and analyzed enriched TF-binding motifs in these regions. Applying this unbiased approach to classical Hodgkin lymphoma (HL), a common B-cell-derived lymphoma with a complex pattern of deregulated TFs, we discovered interferon regulatory factor (IRF) sites among the top enriched motifs. High-level expression of the proinflammatory TF IRF5 was specific to HL cells and crucial for their survival. Furthermore, IRF5 initiated a regulatory cascade in human non-Hodgkin B-cell lines and primary murine B cells by inducing the TF AP-1 and cooperating with NF-κB to activate essential characteristic features of HL. Our strategy efficiently identified a lymphoma type-specific key regulator and uncovered a tumor promoting role of IRF5.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25288773      PMCID: PMC4210307          DOI: 10.1073/pnas.1406985111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.

Authors:  Tadatsugu Taniguchi; Akinori Takaoka
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.

Authors:  B Falini; M Fizzotti; A Pucciarini; B Bigerna; T Marafioti; M Gambacorta; R Pacini; C Alunni; L Natali-Tanci; B Ugolini; C Sebastiani; G Cattoretti; S Pileri; R Dalla-Favera; H Stein
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.

Authors:  B J Barnes; P A Moore; P M Pitha
Journal:  J Biol Chem       Date:  2001-04-12       Impact factor: 5.157

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Authors:  Ralf Küppers; Ulf Klein; Ines Schwering; Verena Distler; Andreas Bräuninger; Giorgio Cattoretti; Yuhai Tu; Gustavo A Stolovitzky; Andrea Califano; Martin-Leo Hansmann; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 6.  Genome sequencing of lymphoid malignancies.

Authors:  Charles G Mullighan
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

7.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

8.  Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes.

Authors:  Betsy J Barnes; Merrill J Kellum; Ann E Field; Paula M Pitha
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.

Authors:  Mariko Watanabe; Yuji Ogawa; Kinji Ito; Masaaki Higashihara; Marshall E Kadin; Lawrence J Abraham; Toshiki Watanabe; Ryouichi Horie
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  23 in total

1.  RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2.

Authors:  Yaakov Maman; Grace Teng; Rashu Seth; Steven H Kleinstein; David G Schatz
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

2.  Onco-exaptation of an endogenous retroviral LTR drives IRF5 expression in Hodgkin lymphoma.

Authors:  A Babaian; M T Romanish; L Gagnier; L Y Kuo; M M Karimi; C Steidl; D L Mager
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

3.  An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.

Authors:  A Lollies; S Hartmann; M Schneider; T Bracht; A L Weiß; J Arnolds; L Klein-Hitpass; B Sitek; M-L Hansmann; R Küppers; M A Weniger
Journal:  Leukemia       Date:  2017-06-29       Impact factor: 11.528

4.  Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.

Authors:  Qianli Wang; Amy Lingel; Vicki Geiser; Zachary Kwapnoski; Luwen Zhang
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 5.  Sequences to Differences in Gene Expression: Analysis of RNA-Seq Data.

Authors:  Polina V Pavlovich; Pierre Cauchy
Journal:  Methods Mol Biol       Date:  2022

Review 6.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2015-03-07       Impact factor: 0.196

7.  A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.

Authors:  Kivia A P de Oliveira; Eva Kaergel; Matthias Heinig; Jean-Fred Fontaine; Giannino Patone; Enrique M Muro; Stephan Mathas; Michael Hummel; Miguel A Andrade-Navarro; Norbert Hübner; Claus Scheidereit
Journal:  Genome Med       Date:  2016-03-17       Impact factor: 11.117

8.  Wellington-bootstrap: differential DNase-seq footprinting identifies cell-type determining transcription factors.

Authors:  Jason Piper; Salam A Assi; Pierre Cauchy; Christophe Ladroue; Peter N Cockerill; Constanze Bonifer; Sascha Ott
Journal:  BMC Genomics       Date:  2015-11-25       Impact factor: 3.969

9.  Dynamic recruitment of Ets1 to both nucleosome-occupied and -depleted enhancer regions mediates a transcriptional program switch during early T-cell differentiation.

Authors:  Pierre Cauchy; Muhammad A Maqbool; Joaquin Zacarias-Cabeza; Laurent Vanhille; Frederic Koch; Romain Fenouil; Marta Gut; Ivo Gut; Maria A Santana; Aurélien Griffon; Jean Imbert; Carolina Moraes-Cabé; Jean-Christophe Bories; Pierre Ferrier; Salvatore Spicuglia; Jean-Christophe Andrau
Journal:  Nucleic Acids Res       Date:  2015-12-15       Impact factor: 16.971

10.  Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature.

Authors:  Pierre Cauchy; Sally R James; Joaquin Zacarias-Cabeza; Anetta Ptasinska; Maria Rosaria Imperato; Salam A Assi; Jason Piper; Martina Canestraro; Maarten Hoogenkamp; Manoj Raghavan; Justin Loke; Susanna Akiki; Samuel J Clokie; Stephen J Richards; David R Westhead; Michael J Griffiths; Sascha Ott; Constanze Bonifer; Peter N Cockerill
Journal:  Cell Rep       Date:  2015-07-23       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.